Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
mRNA | FANCE | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | SNRPA | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | AP003419.11 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-09 |
mRNA | TMED9 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-09 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
mRNA | WDR12 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
mRNA | UCK2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |